Patients wUh a diagnosis of schizophrenia living in long-term care units show high levels of disability. The present study aimed to assess the effectiveness of including a trained therapy dog in an intervention program applied to institutionalized patients with chronic schizophrenia. A randomized, controlled study with blind assessment was conducted. Twenty-four persons with chronic schizophrenia were randomly selected from a register that included all inpatients at Saint John of God's psychiatric hospital in Spain. Patients who agreed to participate (n = 21 ) were randomly assigned to one of the two treatment groups; one group received an intervention assisted by a therapy dog (IGH-D) (12 patients), while the other received the same intervention but without a therapy dog (IG) (9 patients). The assessment items included the Positive and Negative Symptoms Scale (PANSS), the Living Skills Profile (LSP), the Brief World Health Organization Quality of Ufe Assessment (WHOQOL-BREF), and the Satisfaction with Treatment Questionnaire (STQ). Mann Whitney U tests and Wilcoxon signed-rank tests were conducted. Patients in the IG+D group showed significant improvements in the LSP social contact score ip = 0.041 ), in the positive (p = 0.005) and negative symptom dimensions (p = 0.005) and total score of the PANSS (p = 0.0t4), and in quality of life related with social relationships (p = 0.024). Patients in the IG group showed significant positive changes in positive {p = 0.027) and general symptoms (p = 0.046) and total PANSS score (p = 0.027). No differences were found between the two groups before and after the application of the intervention. Introducing a dog into the psychosodal intervention for patients with schizophrenia produced some positive outcomes. However, the results of the study are not conclusive and must be interpreted cautiously. 8 8 f d Dog-Assisted Therapy in the Treatment of Chronic Schizophrenia Inpatients

BackgroundThis study aimed at assessing the effectiveness and safety of repeated administrations of allogeneic bone marrow-derived mesenchymal stem cells (BM-MSCs) primed with tumor necrosis factor (TNF)-α and interferon-γ in an equine model of chemically-induced osteoarthritis. Arthritis was induced in both radio-carpal (RC)-joints by amphotericin-B in 18 ponies, divided into three groups depending on the treatment injected: MSC-naïve (n = 7), MSC-primed (n = 7) and control (n = 4). The study consisted of two phases and used one RC-joint of each animal in each phase, with four months time-lapse, in order to assess two end-points. Clinical, synovial, radiological and ultrasonographic follow-up was performed. At six months, animals were euthanized and both carpi were assessed by magnetic resonance imaging (MRI), gross anatomy, histopathology, histochemistry and gene expression.ResultsClinical and synovial inflammatory signs were quicker reduced in MSC-treated groups and repeated allogeneic administration did not produce adverse reactions, but MSC-primed group showed slight and transient local inflammation after second injection. Radiology and MRI did not show significant differences between treated and control groups, whereas ultrasonography suggested reduced synovial effusion in MSC-treated groups. Both MSC-treated groups showed enhanced cartilage gross appearance at two compared to six months (MSC-naïve, p < 0.05). Cartilage histopathology did not reveal differences but histochemistry suggested delayed progression of proteoglycan loss in MSC-treated groups. Synovium histopathology indicated decreased inflammation (p < 0.01) in MSC-primed and MSC-naïve at two and six months, respectively. At two months, cartilage from MSC-primed group significantly (p < 0.05) upregulated collagen type II (COL2A1) and transforming growth factor (TGF)-β1 and downregulated cyclooxygenase-2 and interleukin (IL)-1β. At six months, MSC-treatments significantly downregulated TNFα (p < 0.05), plus MSC-primed upregulated (p < 0.05) COL2A1, aggrecan, cartilage oligomeric protein, tissue inhibitor of metalloproteinases-2 and TGF-β1. In synovium, both MSC-treatments decreased (p < 0.01) matrix metalloproteinase-13 expression at two months and MSC-primed also downregulated TNFα (p < 0.05) and IL-1β (p < 0.01).ConclusionsBoth MSC-treatments provided beneficial effects, mostly observed at short-term. Despite no huge differences between MSC-treatments, the findings suggested enhanced anti-inflammatory and regulatory potential of MSC-primed. While further research is needed to better understand these effects and clarify immunogenicity implications, these findings contribute to enlarge the knowledge about MSC therapeutics and how they could be influenced.Electronic supplementary materialThe online version of this article (10.1186/s12917-018-1556-3) contains supplementary material, which is available to authorized users.

No abstract

NCT01573637.

No abstract

clinicaltrials.gov Identifier: NCT01041092.

Background: Previous research has shown that various memory errors reflecting failure in the self-monitoring of speech were associated with auditory/verbal hallucinations in schizophrenia patients and with proneness to hallucinations in non-clinical individuals.Method: We administered to 57 schizophrenia patients and 60 healthy participants a verbal memory task involving free recall and recognition of lists of words with different structures (high-frequency, low-frequency, and semantically organisable words). Extra-list intrusions in free recall were tallied, and the response bias reflecting tendency to make false recognitions of non-presented words was computed for each list.Results: In the male patient subsample, extra-list intrusions were positively associated with verbal hallucinations and inversely associated with negative symptoms. In the healthy participants the extra-list intrusions were positively associated with proneness to hallucinations. A liberal response bias in the recognition of the high-frequency words was associated with verbal hallucinations in male patients and with proneness to hallucinations in healthy men. Meanwhile, a conservative response bias for these high-frequency words was associated with negative symptoms in male patients and with social anhedonia in healthy men.Conclusion: Misattribution of inner speech to an external source, reflected by false recollection of familiar material, seems to underlie both clinical and non-clinical hallucinations. Further, both clinical and non-clinical negative symptoms may exert on verbal memory errors an effect opposite to that of hallucinations.

No abstract